News

Technology News

Exosome Touts Prostate Cancer Test Results

Friday, February 27, 2015 5:00:00 AM PDT | VentureDeal
   Orlando, Florida  --  Exosome Diagnostics has announced positive data from its initial clinical study of a new prostate cancer test system.

The new test, which utilizes a non-invasive, urine-based process, aims to "predict high-grade prostate cancer by analyzing biomarkers on exosomal RNA."

The test delivers real-time genetic information that complements PSA and related prognostic factors, without the use of a biopsy-based process.

Exosome said that it has completed enrollment in a much larger clinical validation study with the purpose to confirm the initial data.

It intends to present the results of that study by the middle of 2015, and possibly begin commercializing the test later in the year.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1